Fundraising Fox
🦊/People
Sign in

Martin Smrcina

Founder

Founder at Zafrens

San Diego, California, United States

FoundedZafrens

Find your path to Martin

266 people in our graph share verified history with Martin — schools, employers, funds. One of them is your warm intro.

Mike ZakunlockedMartin: together at Cornell (1993–1994)
×11Martin: together at Cornell

About

Martin Smrcina is Executive Director of Medicinal Chemistry at Zafrens, with 23 years of industrial experience in organic and medicinal chemistry. His work spans synthetic organic chemistry, drug design, solid phase techniques, and peptide synthesis, including the design, synthesis, and characterization of compounds advanced from leads to clinical candidates. He has also taught organic chemistry, with a focus on organic synthesis, reaction mechanisms, and stereochemistry.

Founder at Zafrens

Intro paths

→

In turn, Martin can intro founders to Zafrens's investors below.

Zafrens's investors · 9

Acequia Capital (AceCap)Seattle · $100K – $5M checks · since 2021BlueYard CapitalBerlin · $500K – $5M checks · since 2021FoundersX VenturesSilicon Valley · since 2021Global BrainTokyo · $100K – $184M checks · since 2021HAWKTAILSan Francisco · since 2021Iaso VenturesCambridge · since 2021imec.xpandLeuven · $270K – $5.4M checks · since 2021Prime Movers LabJackson · $2M – $30M checks · since 2021Raptor GroupMiami Beach · since 2021

Co-founders at Zafrens

MNMaina Ndungu
Maina Ndungu

Experience

  1. ZafrensExecutive Director - Medicinal Chemistrycurrent2024 — presentSan Diego, California, United States
  2. ZafrensAssociate Research Fellowcurrent2023 — presentSan Diego, California, United States
  3. Icagen-Omniab Inc.Associate Research Follow2022 — 2023Tucson, Arizona, United States
  4. Icagen - Ligand companyAssociate Research Fellow2020 — 2022Tucson, Arizona, United States
  5. IcagenLead Research Investigator2016 — 2020Tucson, Arizona Area
  6. IcagenSenior Researcher2016
  7. SanofiLead Research Investigator2011 — 2016Tucson, Arizona Area
  8. SanofiPrincipal Research Investigator2005 — 2011Tucson, Arizona Area
  9. AventisPrincipal Research Investigator2000 — 2005Tucson, Arizona Area
  10. Hoechst Marion RousselResearch Investigator1997 — 2000Tucson, Arizona Area
  11. Department of Chemistry, Faculty of Science, Charles UniversityAssistant Professor of Chemistry1990 — 1996Prague, The Capital, Czech Republic

Skills & more

Medical ResearchAnalytical ChemistryResearch SkillsNMR SpectroscopyIR SpectroscopyLC-MSNMR spectrometryMedicinal Chemistry4Clinical ResearchChemistry2Organic Chemistry1Pharmaceutical Industry
+10 moreDrug DesignPeptidesDrug DiscoveryDrug DevelopmentADMEOrganic SynthesisPeptide SynthesisSynthetic Organic ChemistryHigh-Performance Liquid Chromatography (HPLC)Liquid Chromatography-Mass Spectrometry (LC-MS)

Languages Czech · English

From Martin's professional profile.

Frequently asked questions

Who is Martin Smrcina?
Martin Smrcina is Executive Director of Medicinal Chemistry at Zafrens, with 23 years of industrial experience in organic and medicinal chemistry. His work spans synthetic organic chemistry, drug design, solid phase techniques, and peptide synthesis, including the design, synthesis, and characterization of compounds advanced from leads to clinical candidates. He has also taught organic chemistry, with a focus on organic synthesis, reaction mechanisms, and stereochemistry.
Where does Martin Smrcina work?
Martin Smrcina is Founder of Zafrens.
What companies did Martin Smrcina found?
Martin Smrcina founded Zafrens.
Where did Martin Smrcina go to school?
Martin Smrcina studied at Cornell University (Ph.D. Postdoc, Organic Chemistry); Charles University (Master's degree and Ph.D., Organic Chemistry).

Founder mafias

Same school

Shared employers